Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
Colorcon
Express Scripts
Boehringer Ingelheim

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Antroquinonol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Antroquinonol: Sponsors, patents, clinical trial progress

Antroquinonol is an investigational drug.

There have been 9 clinical trials for Antroquinonol. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2013.

The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Golden Biotechnology Corporation, Cheng-Chung Wei, and Chung Shan Medical University.

There are two US patents protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for Antroquinonol
TitleSponsorPhase
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult PatientsGolden Biotechnology CorporationPhase 2
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis BGolden Biotechnology CorporationPhase 2
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis BCheng-Chung WeiPhase 2

See all Antroquinonol clinical trials

Clinical Trial Summary for Antroquinonol

Top disease conditions for Antroquinonol
Top clinical trial sponsors for Antroquinonol

See all Antroquinonol clinical trials

US Patents for Antroquinonol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Antroquinonol   Start Trial Methods and compositions for treating leukemia Golden Biotechnology Corporation (Jersey City, NJ)   Start Trial
Antroquinonol   Start Trial Compounds from antrodia camphorate and their use in treatment of diabetes mellitus National Dong Hwa University (Hualien, TW)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Antroquinonol

Drugname Country Document Number Estimated Expiration Related US Patent
Antroquinonol Australia 2014218938 2033-02-20   Start Trial
Antroquinonol Brazil 112015019924 2033-02-20   Start Trial
Antroquinonol Canada 2901745 2033-02-20   Start Trial
Antroquinonol China 105246470 2033-02-20   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Merck
AstraZeneca
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.